http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107090049-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-14 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
filingDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107090049-B |
titleOfInvention | Arborvitae total starches and its preparing the purposes in immunosuppressive drug |
abstract | The invention belongs to the field of Chinese medicines, be related to a kind of arborvitae total starches, the polysaccharide be from Tibetan medicine Xu Bayuan plant arborvitae ( Sabina pingii var. wilsonii ) Water-soluble polysccharide of preparation is extracted in branches and leaves, the present invention characterizes the structure features such as its sugared content, glucuronic acid content, protein content, molecular weight distribution, monosaccharide composition;Through determination of activity, the results showed that the arborvitae polysaccharide has apparent anticomplementary action, reaches 23~35 μ g/ml to the half effective inhibition concentration of complement activation classical pathway, suitable with positive control medicine heparin sodium activity;LPS can be significantly inhibited simultaneously stimulates the level of lower Turnover of Mouse Peritoneal Macrophages secretion NO, shows it with good anti-inflammatory effect;Arborvitae total starches of the invention can be used for preparing the immunosupress related drugs such as anticomplement, anti-inflammatory. |
priorityDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.